Benzinga | May 13, 2021 11:34AM EDT

Morgan Stanley Maintains Underweight on Phibro Animal Health, Raises Price Target to $22

Morgan Stanley maintains Phibro Animal Health (NASDAQ:PAHC) with a Underweight and raises the price target from $19 to $22.